At the end of the latest market close, Precision BioSciences Inc. (DTIL) was valued at $1.26. In that particular session, Stock kicked-off at the price of $1.30 while reaching the peak value of $1.422 and lowest value recorded on the day was $1.29. The stock current value is $1.39.Recently in News on June 21, 2022, Precision BioSciences Announces $50 Million Offering of Common Stock. Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that it has agreed to sell 35,971,224 shares of its common stock at a price of $1.39 per share, by way of an underwritten offering, for gross proceeds of approximately $50.0 million. The offering is expected to close on or about June 24, 2022, subject to customary closing conditions. All shares of common stock to be sold in the offering will be sold by Precision BioSciences. Precision BioSciences intends to use the net proceeds of the offering to help fund ongoing and planned research and development, and for working capital and general corporate purposes. You can read further details here
Precision BioSciences Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $7.8500 on 01/04/22, with the lowest value was $1.1100 for the same time period, recorded on 06/16/22.
Precision BioSciences Inc. (DTIL) full year performance was -87.19%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Precision BioSciences Inc. shares are logging -90.33% during the 52-week period from high price, and 25.23% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.11 and $14.38.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1120491 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Precision BioSciences Inc. (DTIL) recorded performance in the market was -81.22%, having the revenues showcasing -54.43% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 78.88M, as it employees total of 190 workers.
The Analysts eye on Precision BioSciences Inc. (DTIL)
During the last month, 6 analysts gave the Precision BioSciences Inc. a BUY rating, 1 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.9176, with a change in the price was noted -3.13. In a similar fashion, Precision BioSciences Inc. posted a movement of -69.25% for the period of last 100 days, recording 821,594 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for DTIL is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.04.
Technical rundown of Precision BioSciences Inc. (DTIL)
Raw Stochastic average of Precision BioSciences Inc. in the period of last 50 days is set at 14.51%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 25.45%. In the last 20 days, the company’s Stochastic %K was 17.58% and its Stochastic %D was recorded 11.74%.
Considering, the past performance of Precision BioSciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -81.22%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -83.57%, alongside a downfall of -87.19% for the period of the last 12 months. The shares increased approximately by 14.88% in the 7-day charts and went up by -19.65% in the period of the last 30 days. Common stock shares were lifted by -54.43% during last recorded quarter.